The Vanguard Group, Inc. recently announced the acquisition of new stake in Oracle Corp. (NYSE:ORCL). The institutional investor has increased its shareholding in the Technology company by 5.81% to 140.74 million shares with purchase of 7.73 million shares. This fresh investment now brings its stake to 5.12% valued currently at $14.84 billion. In addition, BlackRock Fund Advisors raised its holdings by 0.76 million to 81.83 million shares. And Geode Capital Management LLC has lifted its position by 6.20% or 1.81 million shares – to 30.92 million shares.
Currently, there are 2.71B common shares owned by the public and among those 1.60B shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 87 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 39 of these insider trades were purchases, accounting for 13,216,204 shares. Insider sales of the common stock occurred on 48 occasions, with total insider shares sold totaling 13,022,325 shares.
The top 3 mutual fund holders in Oracle Corp. are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and SPDR S&P 500 ETF Trust. Vanguard Total Stock Market ETF owns 51.58 million shares of the company’s stock, all valued at over $5.44 billion. The company bought an additional 0.53 million shares recently to bring their total holdings to about 1.88% of the shares outstanding. Vanguard 500 Index Fund bought 0.43 million shares to see its total holdings expand to 38.8 million shares valued at over $4.09 billion and representing 1.41% of the shares outstanding. SPDR S&P 500 ETF Trust sold -0.11 million shares to bring its total holdings to over 19.44 million shares at a value of $2.05 billion. SPDR S&P 500 ETF Trust now owns shares totaling to 0.71% of the shares outstanding.
The company’s stock has a 5-day price change of 4.68% and 1.31% over the past three months. ORCL shares are trading 4.02% year to date (YTD), with the 12-month market performance up to 26.48% higher. It has a 12-month low price of $82.04 and touched a high of $127.54 over the same period. ORCL has an average intraday trading volume of 9.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.28%, 0.11%, and 0.45% respectively.
Institutional ownership of Oracle Corp. (NYSE: ORCL) shares accounts for 43.60% of the company’s 2.71B shares outstanding. Mutual fund holders own 23.60%, while other institutional holders and individual stakeholders account for 42.08% and 20.18% respectively.
It has a market capitalization of $301.47B and a beta (3y monthly) value of 1.01. The stock’s trailing 12-month PE ratio is 30.33, while the earnings-per-share (ttm) stands at $3.62. The company has a PEG of 2.84 and a Quick Ratio of 0.79 with the debt-to-equity ratio at 22.97. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.55% over the week and 1.47% over the month.
Analysts forecast that Oracle Corp. (ORCL) will achieve an EPS of $1.37 for the current quarter, $1.64 for the next quarter and $6.21 for 2025. The lowest estimate earnings-per-share for the quarter is $1.36 while analysts give the company a high EPS estimate of $1.42. Comparatively, EPS for the current quarter was $1.22 a year ago. Earnings per share for the fiscal year are expected to increase by 8.43%, and 11.83% over the next financial year. EPS should shrink at an annualized rate of 10.68% over the next five years, compared to 29.43% over the past 5-year period.
Looking at the support for the ORCL, a number of firms have released research notes about the stock. BMO Capital Markets stated their Market Perform rating for the stock in a research note on December 12, 2023, with the firm’s price target at $130-$126.
